Dyssegmental dysplasia, Silverman-Handmaker type: Unexpected role of perlecan in cartilage development

被引:47
作者
Arikawa-Hirasawa, E
Wilcox, WR
Yamada, Y
机构
[1] NIDCR, Mol Biol Sect, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2001年 / 106卷 / 04期
关键词
dyssegmental dysplasia; Silverman-Handmaker type (DDSH); perlecan; functional null mutations; chondrodysplasia; Schwartz-Jampel syndrome (S[!text type='JS']JS[!/text]);
D O I
10.1002/ajmg.10229
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Dyssegmental dysplasia, Silverman-Handmaker type (DDSH), is a lethal autosomal recessive form of dwarfism with characteristic anisospondylic micromelia. The remarkable similarities in the radiographic, clinical, and chondroosseous morphology of DDSH patients to those of perlecan-null mice led to the identification of mutations in the perlecan gene (HSPG2) of DDSH. Perlecan, a large heparan sulfate proteoglycan, is expressed in various tissues and is a component of all basement membrane extracellular matrices. A chondrodysplasia phenotype caused by the loss of perlecan was unexpected, because cartilage does not have basement membranes. Insertion and splicing mutations in HSPG2 of DDSH were found that were predicted to create a premature termination codon. Immunostaining and biochemical analysis revealed that the mutant perlecan molecules were unstable and not secreted into the extracellular matrix. These results indicate that DDSH is caused by functional null mutations of HSPG2 and that perlecan is essential for cartilage development. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 16 条
  • [1] DYSSEGMENTAL DYSPLASIAS - CLINICAL, RADIOGRAPHIC, AND MORPHOLOGICAL EVIDENCE OF HETEROGENEITY
    ALECK, KA
    GRIX, A
    CLERICUZIO, C
    KAPLAN, P
    ADOMIAN, GE
    LACHMAN, R
    RIMOIN, DL
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 27 (02): : 295 - 312
  • [2] Perlecan is essential for cartilage and cephalic development
    Arikawa-Hirasawa, E
    Watanabe, H
    Takami, H
    Hassell, JR
    Yamada, Y
    [J]. NATURE GENETICS, 1999, 23 (03) : 354 - 358
  • [3] Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene
    Arikawa-Hirasawa, E
    Wilcox, WR
    Le, AH
    Silverman, N
    Govindraj, P
    Hassell, JR
    Yamada, Y
    [J]. NATURE GENETICS, 2001, 27 (04) : 431 - 434
  • [4] PERLECAN, BASAL LAMINA PROTEOGLYCAN, PROMOTES BASIC FIBROBLAST GROWTH FACTOR-RECEPTOR BINDING, MITOGENESIS, AND ANGIOGENESIS
    AVIEZER, D
    HECHT, D
    SAFRAN, M
    EISINGER, M
    DAVID, G
    YAYON, A
    [J]. CELL, 1994, 79 (06) : 1005 - 1013
  • [5] Perlecan maintains the integrity of cartilage and some basement membranes
    Costell, M
    Gustafsson, E
    Aszódi, A
    Mörgelin, M
    Bloch, W
    Hunziker, E
    Addicks, K
    Timpl, R
    Fässler, R
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 147 (05) : 1109 - 1122
  • [6] Handmaker S D, 1977, Birth Defects Orig Artic Ser, V13, P79
  • [7] Matrix proteoglycans: From molecular design to cellular function
    Iozzo, RV
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 : 609 - 652
  • [8] MURDOCH AD, 1992, J BIOL CHEM, V267, P8544
  • [9] Naski MC, 1998, DEVELOPMENT, V125, P4977
  • [10] Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)
    Nicole, S
    Davoine, CS
    Topaloglu, H
    Cattolico, L
    Barral, D
    Beighton, P
    Ben Hamida, C
    Hammouda, H
    Cruaud, C
    White, PS
    Samson, D
    Urtizberea, JA
    Lehmann-Horn, F
    Weissenbach, J
    Hentati, F
    Fontaine, B
    [J]. NATURE GENETICS, 2000, 26 (04) : 480 - 483